Drug Index

Famotidine

 
print

Mechanism :

Famotidine is a competitive inhibitor of histamine H2-receptors. The primary clinically important pharmacologic activity is inhibition of gastric juice secretion. Famotidine reduces the acid and pepsin content, as well as the volume, of basal, nocturnal, and stimulated gastric secretion.


Indication :

• Peptic ulcer

• GERD

• Heartburn


Contraindications :

Hypersensitivity to any component of this medication.


Dosing :

Peptic Ulcer Disease:

1-16 years: 0.5 mg/kg/day once orally at bed time OR 0.25 mg/kg IV every 12 hours; Max: 40 mg/day.

GERD:

Under 3 months: 0.5 mg/kg/day orally once daily upto 8 weeks.

3-12 months: 1 mg/kg/day orally every 12 hours for upto 8 weeks.

1-16 years: 1 mg/kg/day orally in two divided doses; Max: 40 mg/day.

Heartburn:

Under 12 years: Not established.

Above 12 years: 10-20 mg twice daily; may take 15-60 min before eating foods that can cause heartburn.


Adverse Effect :

Headache, dizziness, constipation and diarrhea.

Serious Reactions: Anaphylaxis, Stevens-Johnson syndrome, angioedema, leukopenia, toxic epidermal necrolysis, agranulocytosis, thrombocytopenia, pancytopenia, seizures, arrhythmias, AV block, hepatitis, cholestatic jaundice, interstitial pneumonia, QT prolongation.


Interaction :

Ketoconazole, Triamterene, Delavirdine, Itraconazole, Cefpodoxime, Cyanocobalamin, Indomethacin, Melphalan: Decreased absorption.
Tolazoline: Decreased effect of Tolazoline.



Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-2050% of normal dose
<1020 mg at night (maximum)

Dose in Patients undergoing Renal Replacement Therapies
CAPDNot dialysed. Dose as in GFR<10 mL/min
HDNot dialysed. Dose as in GFR<10 mL/min
HDF/High fluxNot dialysed. Dose as in GFR<10 mL/min
CAV/VVHDNot dialysed. Dose as in GFR=10– 20 mL/min

Hepatic Dose :

Dose adjustment will be needed for pediatric population with hepatic dysfunction because the drug can accumulate, causing toxicity especially in patients with concomitant renal impairment.
08/03/2020 16:22:26 Famotidine
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0